ImmuneCyte Inc. is a global, clinical-stage biopharmaceutical company engaged in the research and development of innovative cell and gene therapeutics, including the fourth generation chimeric antigen receptor (CAR)-T cell, CAR-NK cell, and mononuclear cell therapies, for the treatment of cancer and vascular diseases. With global coronavirus pandemic, ImmuneCyte is also developing a multitiered immunotherapies in the fight against Covid-19. Connect with us at www.immunecyte.com, on Facebook at www.facebook.com/ImmuneCyte and on Instagram @ImmuneCyte.
| Website | https://immunecyte.com/ |
| Employees | View employees |
| Founded | 2019 |
| Address | 185 Technology Drive Suite 150, Irvine, California 92618, US |
| Phone | +1 800-797-6330 |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Other Pharmaceuticals and Biotechnology, Business Services, Other Healthcare Services |
| Competitors | Adaptive Biotechnologies Corp., Cellares, GSK, MacroGenics, Inc., ImmunoGen, Inc., Agenus, アステラス製薬（株）, Amgen, Immunex Corporation, Alder BioPharmaceuticals, Inc. +43 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 325414 Companies |
Looking for a particular ImmuneCyte, Inc. employee's phone or email?
ImmuneCyte, Inc. Questions
ImmuneCyte, Inc. is based in Irvine, California.
The NAICS codes for ImmuneCyte, Inc. are [32, 3254, 32541, 325, 325414].
The SIC codes for ImmuneCyte, Inc. are [28, 283].
Related Companies
